Fig. 1From: Identification of NOTCH4 mutation as a response biomarker for immune checkpoint inhibitor therapyFlowchart of the process used for screening of the study population. A Flowchart of the process used for screening of patients included in the discovery cohort. B Flowchart of the process used for screening of patients included in the validation cohort. C Flowchart of the process used for screening of patients included in the non-ICI-treated cohortBack to article page